Key result
Late first appropriate ICD shock is linked to ~122% higher mortality risk versus early occurrence.
Why the study?
Appropriate ICD shocks are associated with increased mortality and heart failure events, but whether the timing of the first appropriate shock influences prognosis was unknown.
Does the late occurrence of a first appropriate ICD shock (≥1 year) worsen all-cause mortality compared to early occurrence (<1 year) in patients with an ICD?
Observational (n=565)
Does the late occurrence of a first appropriate ICD shock (≥1 year) worsen all-cause mortality compared to early occurrence (<1 year) in patients with an ICD?
A first appropriate ICD shock occurring ≥1 year after implantation is associated with a more than twofold increased risk of all-cause mortality compared to a shock occurring within the first year, primarily driven by heart failure.
Answers are grounded in this paper and cite their sources.
Late first appropriate ICD shock associated with higher mortality; hypothesis-generating for timing-specific risk stratification, needing prospective confirmation.
BACKGROUND: Appropriate implantable cardioverter-defibrillator (ICD) shocks are associated with an increased risk of mortality and heart failure (HF) events. The first appropriate shock may occur late after implantation. However, whether the timing of the first appropriate shock influences prognosis is unknown. This study aimed to evaluate the clinical significance of the timing of the first appropriate shock in patients with ICD. METHODS: This retrospective and observational study enrolled 565 consecutive ICD patients. Patients who received an appropriate shock were divided into the early group (first appropriate shock <1 year after ICD implantation) and late group (first appropriate shock ≥1 year after ICD implantation). All-cause mortality was compared between the two groups. RESULTS: Over a median follow-up of 5.6 years, 112 (19.8%) patients received an appropriate shock, including 32 patients (28.6%) in the early group and 80 patients (71.4%) in the late group. Comparisons of baseline characteristics at ICD implantation revealed that the late group was more likely to receive cardiac resynchronization therapy (66.3% vs. 31.3%, p < 0.001), ICD for primary prevention (60.0% vs. 31.3%, p = 0.001), and angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker treatment (88.8% vs. 71.9%, p = 0.028). Survival after shock was significantly worse in the late group than in the early group (p = 0.027). In multivariable Cox proportional hazards analysis, the late group had an increased risk of all-cause mortality compared with the early group (HR: 2.22; 95% CI 1.01-4.53; p = 0.029). In both groups, the most common cause of death was HF. CONCLUSIONS: Late occurrence of the first appropriate ICD shock was associated with a worse prognosis compared with early occurrence of the first appropriate shock. Cardiac death was the most common cause of death in patients who experienced late occurrence of the first appropriate ICD shock, resulting from HF in most cases.
No takes yet. Share an insight, caveat, or question.
Kishihara et al. (2022) conducted an observational in Patients with an implantable cardioverter-defibrillator (ICD) (n=565). Late first appropriate shock (≥1 year after ICD implantation) vs. Early first appropriate shock (<1 year after ICD implantation) was evaluated on All-cause mortality (HR 2.22, 95% CI 1.01-4.53, p=0.029). Late occurrence of the first appropriate ICD shock (≥1 year post-implantation) was associated with an increased risk of all-cause mortality compared with early occurrence.
Synapse has enriched 10 related papers. Consider them for comparative context: